Sanjib Bhakta

3.6k total citations
100 papers, 2.7k citations indexed

About

Sanjib Bhakta is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Sanjib Bhakta has authored 100 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Infectious Diseases, 53 papers in Molecular Biology and 38 papers in Epidemiology. Recurrent topics in Sanjib Bhakta's work include Tuberculosis Research and Epidemiology (51 papers), Cancer therapeutics and mechanisms (30 papers) and Mycobacterium research and diagnosis (26 papers). Sanjib Bhakta is often cited by papers focused on Tuberculosis Research and Epidemiology (51 papers), Cancer therapeutics and mechanisms (30 papers) and Mycobacterium research and diagnosis (26 papers). Sanjib Bhakta collaborates with scholars based in United Kingdom, India and United States. Sanjib Bhakta's co-authors include Dimitrios Evangelopoulos, Antima Gupta, Arundhati Maitra, Simon Gibbons, Joyoti Basu, Juan Guzman, Tulika Munshi, Edith Sim, Timothy D. McHugh and N.H. Keep and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Sanjib Bhakta

99 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanjib Bhakta United Kingdom 33 1.3k 1.1k 666 548 295 100 2.7k
Julian G. Hurdle United States 28 1.2k 0.9× 1.1k 1.0× 444 0.7× 498 0.9× 335 1.1× 58 2.6k
Sudagar S. Gurcha United Kingdom 32 1.6k 1.2× 1.2k 1.1× 1.0k 1.5× 789 1.4× 172 0.6× 61 3.1k
Sajjad Ahmad Pakistan 34 2.4k 1.8× 758 0.7× 508 0.8× 734 1.3× 234 0.8× 228 4.4k
L A Collins United States 13 880 0.7× 971 0.9× 685 1.0× 658 1.2× 154 0.5× 15 2.3k
Ruben C. Hartkoorn Switzerland 30 1.2k 0.9× 1.8k 1.6× 1.0k 1.6× 382 0.7× 346 1.2× 55 2.8k
Apoorva Bhatt United Kingdom 31 1.4k 1.1× 1.6k 1.4× 1.4k 2.1× 379 0.7× 313 1.1× 72 3.0k
José A. Aı́nsa Spain 28 865 0.7× 1.3k 1.1× 1.0k 1.5× 253 0.5× 649 2.2× 66 2.3k
Maria Rosalia Pasca Italy 32 1.4k 1.1× 1.5k 1.4× 1.0k 1.5× 745 1.4× 465 1.6× 73 3.0k
Yusuf Akhter India 27 1.3k 1.0× 460 0.4× 499 0.7× 233 0.4× 164 0.6× 150 2.4k
Anand Anbarasu India 31 1.4k 1.0× 372 0.3× 356 0.5× 235 0.4× 476 1.6× 167 2.7k

Countries citing papers authored by Sanjib Bhakta

Since Specialization
Citations

This map shows the geographic impact of Sanjib Bhakta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjib Bhakta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjib Bhakta more than expected).

Fields of papers citing papers by Sanjib Bhakta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanjib Bhakta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjib Bhakta. The network helps show where Sanjib Bhakta may publish in the future.

Co-authorship network of co-authors of Sanjib Bhakta

This figure shows the co-authorship network connecting the top 25 collaborators of Sanjib Bhakta. A scholar is included among the top collaborators of Sanjib Bhakta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjib Bhakta. Sanjib Bhakta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thakur, Abhishek, et al.. (2024). Mycobactin analogue interacting with siderophore efflux-pump protein: insights from molecular dynamics simulations and whole-cell assays. SHILAP Revista de lepidopterología. 3. 1362516–1362516. 1 indexed citations
2.
3.
Yadav, Pragya D., P. Mukherjee, Samsher Singh, et al.. (2023). Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial Antibiotics. Molecules. 28(24). 8115–8115. 2 indexed citations
4.
Danquah, Cynthia Amaning, et al.. (2022). Antibacterial and Antifungal Activities of Andrographolide in Combination with Antimicrobial Drugs. SHILAP Revista de lepidopterología. 4 indexed citations
5.
Bhakta, Sanjib, et al.. (2022). Role of AmpC-Inducing Genes in Modulating Other Serine Beta-Lactamases in Escherichia coli. Antibiotics. 11(1). 67–67. 4 indexed citations
6.
Danquah, Cynthia Amaning, Theresa Appiah Agana, Phanankosi Moyo, et al.. (2022). The Phytochemistry and Pharmacology of Tulbaghia, Allium, Crinum and Cyrtanthus: ‘Talented’ Taxa from the Amaryllidaceae. Molecules. 27(14). 4475–4475. 8 indexed citations
7.
Danquah, Cynthia Amaning, Isaac Kingsley Amponsah, Abraham Yeboah Mensah, et al.. (2021). Investigating Ghanaian Allium Species for Anti-Infective and Resistance-Reversal Natural Product Leads to Mitigate Multidrug-Resistance in Tuberculosis. Antibiotics. 10(8). 902–902. 7 indexed citations
8.
Yasmin, Hadida, Praveen M. Varghese, Sanjib Bhakta, & Uday Kishore. (2021). Pathogenesis and Host Immune Response in Leprosy. Advances in experimental medicine and biology. 1313. 155–177. 7 indexed citations
10.
Pferschy‐Wenzig, Eva‐Maria, Olaf Kunert, Liam Martin, et al.. (2020). Antimicrobial and Efflux Pump Inhibitory Activity of Carvotacetones from Sphaeranthus africanus Against Mycobacteria. Antibiotics. 9(7). 390–390. 19 indexed citations
11.
Bhakta, Sanjib, et al.. (2020). Bioactive Compounds from the Bornean Endemic Plant Goniothalamus longistipetes. Antibiotics. 9(12). 913–913. 3 indexed citations
12.
Bhakta, Sanjib, et al.. (2019). Whole-Cell Assays for Discovering Novel Efflux Inhibitorsfor Use as Antibiotic Adjuvants. 1(2). 34–37. 1 indexed citations
13.
Lu, Lu, et al.. (2019). Human Antimicrobial RNases Inhibit Intracellular Bacterial Growth and Induce Autophagy in Mycobacteria-Infected Macrophages. Frontiers in Immunology. 10. 1500–1500. 23 indexed citations
14.
Saifullah, Bullo, et al.. (2017). Novel Anti-Tuberculosis Nanodelivery Formulation of Ethambutol with Graphene Oxide. Molecules. 22(10). 1560–1560. 24 indexed citations
17.
Guzman, Juan, Dimitrios Evangelopoulos, Tulika Munshi, et al.. (2016). DNA sequence-selective C8-linked pyrrolobenzodiazepine–heterocyclic polyamide conjugates show anti-tubercular-specific activities. The Journal of Antibiotics. 69(12). 843–849. 12 indexed citations
18.
Maitra, Arundhati, et al.. (2015). Tackling tuberculosis: Insights from an international TB Summit in London. Virulence. 6(6). 661–672. 3 indexed citations
19.
Guzman, Juan, Dimitrios Evangelopoulos, Antima Gupta, et al.. (2013). Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay. BMJ Open. 3(6). e002672–e002672. 68 indexed citations
20.
Shiu, Winnie Ka Po, John P. Malkinson, M. Mukhlesur Rahman, et al.. (2013). A new plant-derived antibacterial is an inhibitor of efflux pumps in Staphylococcus aureus. International Journal of Antimicrobial Agents. 42(6). 513–518. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026